查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586221

腦脊髓液管理市場：按產品、最終用戶分類 - 全球預測 2025-2030 年

Cerebral Spinal Fluid Management Market by Product (CSF Drainage, CSF Shunts), End-User (Adult, Geriatric, Pediatric) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年腦脊髓液管理市場價值為16.3億美元，預計到2024年將達到17.3億美元，複合年成長率為6.23%，預計到2030年將達到24.9億美元。

腦脊髓液 (CSF) 管理包括調節腦脊髓液的產生、循環和吸收的技術和設備，以解決水腦症和顱內壓波動等問題。對腦脊髓液管理的迫切需求源自於腦脊髓液在保護腦部、清除廢棄物和維持顱內壓方面的作用。應用範圍涵蓋神經病學、神經外科和小兒科，分流器和外部引流系統等設備用於醫院和醫療機構。腦脊髓液分流系統的技術進步、神經系統疾病盛行率的增加以及易患神經退化性疾病的老年人口的增加推動了市場成長。機會在於開發微創手術技術，結合物聯網和人工智慧來監測和管理腦脊髓液動態，以及改善患者的治療結果。然而，仍存在限制可及性的挑戰，包括與分流故障相關的併發症、感染疾病和手術干預的高成本。此外，市場面臨嚴格的監管要求和緩慢的核准流程，這可能會阻礙創新產品的推出。一個重要的創新領域是探索用於分流開發的生物可吸收材料，減少長期併發症。此外，應用人工智慧主導的演算法進行即時監測和預測分析有可能顯著改善臨床決策。企業需要專注於與研究機構的策略夥伴關係關係，以推動創新並快速確保監管合規性。該市場的特點是現有醫療設備公司競爭激烈，新參與企業需要透過技術創新和改進的客戶支援服務來脫穎而出。注重研發和了解當地市場動態對於在不斷變化的環境中抓住機會至關重要。總體而言，腦脊髓液管理的未來在於技術與醫學的無縫整合，以提供高效、經濟高效且對患者友好的解決方案。

主要市場統計
基準年[2023] 16.3億美元
預測年份 [2024] 17.3億美元
預測年份 [2030] 24.9億美元
複合年成長率（%） 6.23%

市場動態：揭示快速發展的腦脊髓液管理市場的關鍵市場洞察

供需的動態交互作用正在改變腦脊髓液管理市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 水腦症和神經系統疾病的盛行率增加
    • 增加每個國家獲得更高品質醫療保健服務的機會
    • 政府努力改善醫療基礎設施
  • 市場限制因素
    • 手術費用高
  • 市場機會
    • 腦脊髓液管理的技術進步與發展
    • 快速投資正在進行的腦屏障和腦液研究計劃
  • 市場挑戰
    • 世界各地缺乏熟練的醫療保健專業人員

波特五力：駕馭腦脊髓液管理市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對腦脊髓液管理市場的外部影響

外部宏觀環境因素在塑造腦脊髓液管理市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解腦脊髓液管理市場的競爭格局

腦脊髓液管理市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣腦脊髓液管理市場供應商的績效評估

FPNV 定位矩陣是評估腦脊髓液管理市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了腦脊髓液管理市場的成功之路

腦脊髓液管理市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群中水腦症和神經系統疾病的盛行率不斷增加
      • 擴大整個經濟領域獲得更高品質醫療保健服務的機會
      • 政府努力改善醫療基礎設施
    • 抑制因素
      • 手術費用高
    • 機會
      • CSF 管理的技術進步與發展
      • 快速投資正在進行的與腦屏障和腦液相關的研究計劃
    • 任務
      • 全球缺乏熟練的醫療保健專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章腦脊髓液管理市場：依產品

  • 腦脊髓液引流
  • 腦脊髓液分流術

第7章腦脊髓液管理市場：依最終使用者分類

  • 成人用
  • 老年病
  • 小兒科

第8章美洲腦脊髓液管理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區腦脊髓液管理市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的腦脊髓液管理市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • B. Braun SE
  • BeckerSmith Medical, Inc.
  • BIcakcIlar TIbbi Cihazlar Sanayi ve Ticaret AS
  • Delta Surgical
  • DESU MEDIKAL AS
  • G.Surgiwear Ltd.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Kaneka Medix Corporation
  • Lyfboat Technologies Pvt. Ltd.
  • Medtronic PLC
  • Moller Medical GmbH
  • Natus Medical Incorporated
  • SALVAVIDAS PHARMACEUTICAL PVT. LTD
  • Siemens AG
  • SOPHYSA SA
  • Spiegelberg GmbH & Co. KG
Product Code: MRR-AD36CD898157

The Cerebral Spinal Fluid Management Market was valued at USD 1.63 billion in 2023, expected to reach USD 1.73 billion in 2024, and is projected to grow at a CAGR of 6.23%, to USD 2.49 billion by 2030.

Cerebral Spinal Fluid (CSF) management involves techniques and devices that regulate the production, circulation, and absorption of cerebral spinal fluid, addressing conditions like hydrocephalus and intracranial pressure fluctuations. The critical necessity for CSF management arises from its role in cushioning the brain, removing waste, and maintaining intracranial pressure. Its applications span across neurology, neurosurgery, and pediatrics, with devices like shunts and external drainage systems being used in hospitals and healthcare facilities. Market growth is propelled by technological advancements in CSF shunt systems, increasing prevalence of neurological disorders, and a rising geriatric population prone to neurodegenerative diseases. Opportunities lie in the development of minimally invasive surgical techniques and the incorporation of IoT and AI to monitor and manage CSF dynamics, enhancing patient outcomes. However, challenges persist, including complications related to shunt malfunction, infections, and the high cost of surgical interventions, which can limit accessibility. Furthermore, the market faces stringent regulatory requirements and a slow approval process that can hinder the introduction of innovative products. A significant area of innovation is the exploration of bioresorbable materials for shunt development, reducing long-term complications. In addition, the application of AI-driven algorithms for real-time monitoring and predictive analytics could dramatically improve clinical decision-making. Companies must focus on strategic partnerships with research institutions to drive innovation and secure regulatory compliance swiftly. The market is characterized by intense competition with the presence of established medical device firms, requiring new entrants to differentiate through technological innovation and improved customer support services. Emphasizing R&D and understanding regional market dynamics are crucial for capturing opportunities in this evolving landscape. Overall, the future of CSF management lies in the seamless integration of technology and medicine to provide efficient, cost-effective, and patient-friendly solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 1.63 billion
Estimated Year [2024] USD 1.73 billion
Forecast Year [2030] USD 2.49 billion
CAGR (%) 6.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cerebral Spinal Fluid Management Market

The Cerebral Spinal Fluid Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of hydrocephalus and neurological disorders among population
    • Increasing access to better quality healthcare services across economies
    • Government initiative to improve healthcare infrastructure
  • Market Restraints
    • High cost of surgical procedures
  • Market Opportunities
    • Technological advancements and developments in CSF management
    • Rapid investments in ongoing research projects related to brain barriers and brain fluids
  • Market Challenges
    • Dearth of skilled healthcare professionals worldwide

Porter's Five Forces: A Strategic Tool for Navigating the Cerebral Spinal Fluid Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cerebral Spinal Fluid Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cerebral Spinal Fluid Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cerebral Spinal Fluid Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cerebral Spinal Fluid Management Market

A detailed market share analysis in the Cerebral Spinal Fluid Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cerebral Spinal Fluid Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cerebral Spinal Fluid Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cerebral Spinal Fluid Management Market

A strategic analysis of the Cerebral Spinal Fluid Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cerebral Spinal Fluid Management Market, highlighting leading vendors and their innovative profiles. These include B. Braun SE, BeckerSmith Medical, Inc., BIcakcIlar TIbbi Cihazlar Sanayi ve Ticaret A.S., Delta Surgical, DESU MEDIKAL A.S., G.Surgiwear Ltd., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Kaneka Medix Corporation, Lyfboat Technologies Pvt. Ltd., Medtronic PLC, Moller Medical GmbH, Natus Medical Incorporated, SALVAVIDAS PHARMACEUTICAL PVT. LTD, Siemens AG, SOPHYSA SA, and Spiegelberg GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Cerebral Spinal Fluid Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across CSF Drainage and CSF Shunts.
  • Based on End-User, market is studied across Adult, Geriatric, and Pediatric.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of hydrocephalus and neurological disorders among population
      • 5.1.1.2. Increasing access to better quality healthcare services across economies
      • 5.1.1.3. Government initiative to improve healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of surgical procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and developments in CSF management
      • 5.1.3.2. Rapid investments in ongoing research projects related to brain barriers and brain fluids
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled healthcare professionals worldwide
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cerebral Spinal Fluid Management Market, by Product

  • 6.1. Introduction
  • 6.2. CSF Drainage
  • 6.3. CSF Shunts

7. Cerebral Spinal Fluid Management Market, by End-User

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Geriatric
  • 7.4. Pediatric

8. Americas Cerebral Spinal Fluid Management Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cerebral Spinal Fluid Management Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cerebral Spinal Fluid Management Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun SE
  • 2. BeckerSmith Medical, Inc.
  • 3. BIcakcIlar TIbbi Cihazlar Sanayi ve Ticaret A.S.
  • 4. Delta Surgical
  • 5. DESU MEDIKAL A.S.
  • 6. G.Surgiwear Ltd.
  • 7. Integra LifeSciences Corporation
  • 8. Johnson & Johnson Services, Inc.
  • 9. Kaneka Medix Corporation
  • 10. Lyfboat Technologies Pvt. Ltd.
  • 11. Medtronic PLC
  • 12. Moller Medical GmbH
  • 13. Natus Medical Incorporated
  • 14. SALVAVIDAS PHARMACEUTICAL PVT. LTD
  • 15. Siemens AG
  • 16. SOPHYSA SA
  • 17. Spiegelberg GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. CEREBRAL SPINAL FLUID MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CEREBRAL SPINAL FLUID MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CEREBRAL SPINAL FLUID MANAGEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY CSF DRAINAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM CEREBRAL SPINAL FLUID MANAGEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. CEREBRAL SPINAL FLUID MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. CEREBRAL SPINAL FLUID MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023